Revocation of NY N276739 and HQ 957022; Classification of sodium bicarbonate cartridges/bags
Reasoning
Revocation of NY N276739 and HQ 957022; Classification of sodium bicarbonate cartridges/bags
Cite this ruling
CBP Ruling H312361 (30049092): Revocation of NY N276739 and HQ 957022; Classification of sodium bicarbonate cartridges/bags
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Anti-Itch Cream (Item No. 0053), Acne Treatment Cream (Item No. 0054), Hemorrhoidal Ointment (Item No. 0056), Oral Pain Relief Ointment (Item No. 0057) and Muscle & Joint Pain Relief Gel (Item No. 0059) over-the-counter medicaments, from Korea
The tariff classification of Anti-Itch Cream (Item No. 0053), Acne Treatment Cream (Item No. 0054), Hemorrhoidal Ointment (Item No. 0056), Oral Pain Relief Ointment (Item No. 0057) and Muscle & Joint Pain Relief Gel (Item No. 0059) over-the-counter medicaments, from Korea
The tariff classification of MLN608, imported in bulk and measured-dose forms, for use in Phase 1 clinical trials, from the United Kingdom and Canada
The tariff classification of IDD-D™ Propofol Injectable Emulsion 2%, imported put up in vials for use in Phase III clinical trials, from Sweden
The tariff classification of liquid-filled glass vials ("cartridges") containing the investigational drug Exenatide (CAS-141732-76-5) as the active ingredient, and the tariff classification of a disposable pen injector fitted with a non-removable, liquid-filled glass vial ("cartridge") containing the investigational new drug Exenatide as the active ingredient, both from the United Kingdom